Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

958
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
958
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.0K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate-driven spatial patterns of diversity, phenology, and habitat suitability in Pyrenaria (Theaceae) across Northeast India.

Scientific reports·2026
Same author

Bioactive Effects of Astragalus aureus Willd. Extracts on Antioxidant and Antimicrobial Properties and Shelf-Life Extension of Fish Fillets.

Applied biochemistry and biotechnology·2026
Same author

Antimycobacterial peptides as natural therapeutics for tuberculosis: mechanisms and structural features.

Frontiers in antibiotics·2026
Same author

Antimicrobial peptides: emerging next-generation strategy for sustainable plant disease management.

Frontiers in antibiotics·2026
Same author

The Gut Gambit: A Review of How Microbial Imbalance Fuels Metabolic Mayhem.

Nutrients·2026
Same author

Overcoming Complexity: Percutaneous Embolization for Hepatic Artery Pseudoaneurysms in Hereditary Hemorrhagic Telangiectasia (HHT).

The Indian journal of radiology & imaging·2026

Related Experiment Video

Updated: Nov 16, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.1K

Eosinophil: a central player in modulating pathological complexity in asthma.

Pulak Pritam1, Sanjeet Manna1, Abhishek Sahu2

  • 1Regional Institute of Biotechnology, Bhubaneswar, Odisha, India.

Allergologia Et Immunopathologia
|February 28, 2021
PubMed
Summary

Eosinophils are key inflammatory cells in asthma. Their activation drives asthma severity by releasing damaging molecules and interacting with other cells, leading to complex allergic responses.

Keywords:
allergyasthmabronchoconstrictioneosinophilinflammation

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.9K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.2K

Related Experiment Videos

Last Updated: Nov 16, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.1K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.9K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.2K

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Eosinophils are central inflammatory cells in allergic and non-allergic asthma.
  • Eosinophilic asthma is a heterogeneous phenotype where eosinophil activation correlates with disease severity.
  • Activated eosinophils express adhesion molecules and secrete factors influencing asthma progression.

Purpose of the Study:

  • To explore regulatory determinants of eosinophil activation in asthma.
  • To understand the role of eosinophils in modulating asthma phenotypes.
  • To review the mechanisms linking eosinophil activation to asthma severity.

Main Methods:

  • Literature review using PubMed and Medline databases.
  • Analysis of scientific literature on eosinophil biology and asthma.
  • Synthesis of current research on eosinophil activation pathways.

Main Results:

  • Activated eosinophils release potent mediators like eosinophil cationic protein (ECP), contributing to tissue damage.
  • Eosinophil activation is linked to other immune cells, exacerbating bronchoconstriction, inflammation, and fibrosis.
  • Cell adhesion molecules on activated eosinophils serve as severity markers.

Conclusions:

  • Eosinophil activation is a critical driver of asthma severity and complex phenotypes.
  • Understanding eosinophil determinants is crucial for managing severe asthma.
  • Targeting eosinophil activation pathways may offer therapeutic strategies for asthma.